ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,751.07
0.90%
Dow Jones
42,352.75
0.81%
US Dollar vs MXN
19.287
0.00%
Brent Oil
77.97
0.00%
Bitcoin
62,098.49
0.04%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Cadrenal Therapeutics Inc (CVKD) Cotización

Cadrenal Therapeutics Inc

Cadrenal Therapeutics Inc (CVKD)

NASDAQ
12.00
0.60
(5.26%)
Cerrado 04 Octubre 3:00PM
Delayed by 15 minutes
12.00
0.00
(0.00%)
Fuera de horario: 5:55PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
12.00
Postura de Compra
11.30
Postura de Venta
12.55
Volume Operado de la Acción
37,065
11.79 Rango del Día 12.2825
5.40 Rango de 52 semanas 32.55
Capitalización de Mercado [m]
12.807M
Precio Anterior
11.40
Precio de Apertura
12.00
Hora
1
@
11.87
Última hora de negociación
Volumen financiero
US$ 444,366
Precio Promedio Ponderado
11.9888
Volumen promedio (3 m)
126,347
Acciones en circulación
1,067,231
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.53
Beneficio por acción (BPA)
-7.83
turnover
-
Beneficio neto
-8.36M

Acerca de Cadrenal Therapeutics Inc

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tec... Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.cadrenal.com
Sede
Middletown, Delaware, USA
Fundado
-
Cadrenal Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVKD. The last closing price for Cadrenal Therapeutics was US$11.40. Over the last year, Cadrenal Therapeutics shares have traded in a share price range of US$ 5.40 to US$ 32.55.

Cadrenal Therapeutics currently has 1,067,231 shares in issue. The market capitalisation of Cadrenal Therapeutics is US$12.17 million. Cadrenal Therapeutics has a price to earnings ratio (PE ratio) of -1.53.

CVKD Últimas noticias

Más noticias

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

4 horas hace
Edgar (US Regulatory)

Form 8-K - Current report

25 Septiembre 2024
Edgar (US Regulatory)

Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference

Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference PR Newswire PONTE VEDRA, Fla., Sept. 23, 2024 PONTE VEDRA, Fla., Sept. 23, 2024 /PRNewswire/ -- Cadrenal...

23 Septiembre 2024
PR Newswire (US)

Form 8-K - Current report

05 Septiembre 2024
Edgar (US Regulatory)

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients PR Newswire PONTE VEDRA, Fla., Aug. 22, 2024 PONTE VEDRA, Fla., Aug. 22, 2024...

22 Agosto 2024
PR Newswire (US)

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients PR Newswire PONTE VEDRA, Fla., Aug. 20, 2024 Analysis features the...

20 Agosto 2024
PR Newswire (US)

Form 8-K - Current report

20 Agosto 2024
Edgar (US Regulatory)

Form 8-K - Current report

16 Agosto 2024
Edgar (US Regulatory)

Cadrenal Therapeutics to Present at Upcoming Investor Conferences

Cadrenal Therapeutics to Present at Upcoming Investor Conferences PR Newswire PONTE VEDRA, Fla., Aug. 14, 2024 PONTE VEDRA, Fla., Aug. 14, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc...

14 Agosto 2024
PR Newswire (US)

Form 8-K - Current report

08 Agosto 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-2.87-19.300605245514.8715.0611.014538712.78309927CS
44.267155.18110928637.732915.3686.894262811.74847671CS
124.966570.6120708047.033515.3685.71263477.34806542CS
263.01533.55592654428.98515.3685.41729446.82859273CS
521.514.285714285710.532.555.418674611.57601878CS
156-73.65-85.989492119185.65101.255.420959622.52426918CS
260-73.65-85.989492119185.65101.255.420959622.52426918CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CHSNChanson International Holding
US$ 11.22
(269.08%)
14.74M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
228.39M
ENTOEntero Therapeutics Inc
US$ 0.60
(72.20%)
10.42M
BENFBeneficient
US$ 1.8914
(58.94%)
108.3M
FORDForward Industries Inc
US$ 5.3254
(52.15%)
18.44M
ADDColor Star Technology Company Ltd
US$ 0.2701
(-39.98%)
14.35M
DUOFangDD Network Group Ltd
US$ 2.53
(-32.89%)
27.74M
ICCTiCoreConnect Inc
US$ 0.4102
(-31.50%)
1.65M
ZENAZenaTech Inc
US$ 3.91
(-29.55%)
212.12k
SPAISafe Pro Group Inc
US$ 1.93
(-25.77%)
238.67k
NVDANVIDIA Corporation
US$ 124.92
(1.68%)
244.44M
PEVPhoenix Motor Inc
US$ 1.0607
(205.24%)
228.39M
SQQQProShares UltraPro Short QQQ
US$ 7.43
(-3.63%)
184.42M
NCNCnoco noco Inc
US$ 0.144
(8.60%)
147.34M
BENFBeneficient
US$ 1.8914
(58.94%)
108.3M

CVKD Discussion

Ver más
MRc2 MRc2 1 semana hace
$CVKD~ $20.00 Target eom
👍️0
TradeSmart.ai TradeSmart.ai 1 semana hace
This thing finally moving huh $CVKD
👍️0
tradernewstip tradernewstip 2 semanas hace
$CVKD BIG NEWS : New Blood Thinner Ready for Phase 3; Initiating Coverage of Cadrenal
Therapeutics, Inc
Zack Smallcap Research report - https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_09162024_CVKD_Bautz.pdf
👍️0
moondogaz moondogaz 3 semanas hace
With all do respect...this one turned out nice...ty.
👍️0
jwrmo jwrmo 3 semanas hace
Anyone know when exactly this meeting with the FDA will take place?
👍️0
TradeSmart.ai TradeSmart.ai 3 semanas hace
Excellent move, much more to come $CVKD
👍️ 1
TradeSmart.ai TradeSmart.ai 3 semanas hace
Heart disease $200 Billion problem and they should have a very nice niche of it with their upcoming treatment. Let’s see gimme $100
👍️ 1
jwrmo jwrmo 3 semanas hace
Its prime time for news and this is dropping. I say Buy.
👍️0
jwrmo jwrmo 3 semanas hace
I dont understand why this is dropping. I am going to hold though because the price is predicted to get to 52.00.
👍️0
moondogaz moondogaz 1 mes hace
Volume increasing
👍️0
tradernewstip tradernewstip 1 mes hace
$CVKD Chart looks ready to move higher imo https://schrts.co/hfdruFjZ
👍️0
tradernewstip tradernewstip 1 mes hace
$CVKD Research Report must Read - https://bigstocks.com/cadrenal-therapeutics/
👍️0
tradernewstip tradernewstip 1 mes hace
$CVKD 1 Month bullish chart https://schrts.co/ijBMJKCK
👍️0
tradernewstip tradernewstip 1 mes hace
$CVKD Strong buy from #tradingview https://www.tradingview.com/symbols/NASDAQ-CVKD/technicals/
👍️0
tradernewstip tradernewstip 1 mes hace
$CVKD Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients https://finance.yahoo.com/news/cadrenal-therapeutics-announces-upcoming-type-130000800.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via
@YahooFinance
👍️0
tradernewstip tradernewstip 1 mes hace
$CVKD Volume precedes price action, following trend pattern could see reversal any time any days imo!
https://schrts.co/hGXgHbiy
👍️0
moondogaz moondogaz 1 mes hace
Fine as wine.....
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD 8 BUCKS, LETS SEE 9.00
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD HERE COMES 8 BUCKS
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD...WE SEE 8 BUCKS TODAY OR TOMORROW
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD...8 BUCKS AROUND THE CORNER
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD...8 DOLLA CLOSING IN!!!
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
here comes 8 dolla....lmao
👍️0
KISSINGER KISSINGER 1 mes hace
Do not listen to this guy. Here is his last recco which is now under $2.00

TrendTrade2016

Re: None

Friday, August 02, 2024 8:34:21 AM

Post#
4
of 13
VSEE HERE COMES 7 BUCKS
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD 8 BUCKS COMING TO TOWN
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD...LETS SEE 8 DOLLA
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD...THERE SHE GOES
👍️0
TrendTrade2016 TrendTrade2016 1 mes hace
CVKD...POST SPLIT BEASTING...1 MILLY FLOT
👍️0
gail gail 2 meses hace
its trying to inch up now, lets ….

….

see what happens here.
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
DILUTE INTO NEWS
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
CVKD BIG NEWS
👍️0
Imokhopeur Imokhopeur 4 meses hace
Green time run here, partnerships and approval coming in this order imo!
👍️ 1
nothing-but-patience nothing-but-patience 5 meses hace
Earnings and possible announcements coming this week. Tick freaking tock...
👍️0
Imokhopeur Imokhopeur 5 meses hace
Steady rise ahead imo
👍️0
Imokhopeur Imokhopeur 5 meses hace
That’s my thought
👍️0
nothing-but-patience nothing-but-patience 5 meses hace
This one checks all of the boxes and at this entry point, it should be a no brainer
👍️0
Imokhopeur Imokhopeur 5 meses hace
IMO it’s time to buy!
👍️0
Imokhopeur Imokhopeur 5 meses hace
That’s fair.
👍️0
nothing-but-patience nothing-but-patience 5 meses hace
Tecarfarin will be brought to market. Question is, by who and when?
👍️0
Klinsmann Klinsmann 6 meses hace
It looks settled and ready for reversal. On close watch so far
👍️0
Imokhopeur Imokhopeur 6 meses hace
It’s going to move north again, imo!
👍️0
Monksdream Monksdream 6 meses hace
CVKD new 52 lo
👍️0
Awl416 Awl416 6 meses hace
Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
👍️0
buccaneer1961 buccaneer1961 8 meses hace
Oh ok
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
DON'T OWN IT ANY LONGER
👍️0
buccaneer1961 buccaneer1961 8 meses hace
How about again?
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
CVKD....BEAUTIFUL PLAY...OUT AT 2 BUCKS BACK IN AT 1.10...LETS DO IT ALL OVER!!!
🚫 1
Agoura Guy Agoura Guy 8 meses hace
BEWARE OF THE CRIMINAL STOCK PROMOTER FROM NOVA SCOTIA, CANADA. THE SEC IS AFTER HIM FOR MULTIPLE SECURITIES VIOLATIONS!!!!!!!

CVKD IS JUST ONE OF MANY PUMP AND DUMPS THIS MAGGOT FRONT RUNS AND DUMPS ON SUCKERS!!!!!


👍️ 1 🚫 1
TrendTrade2016 TrendTrade2016 8 meses hace
The clown watch and learn
🚫 1
Nadendla Nadendla 8 meses hace
CVKD.. we have a sinker..

👍️0

Su Consulta Reciente

NASDAQ
CVKD
Cadrenal Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados